Open Label Trial of Add on Lacosamide Versus High Dose Levetiracetam Monotherapy in Patients With Breakthrough Seizures
Jong Woo Lee(Harvard University), Page B. Pennell(University of Pittsburgh), Barbara A. Dworetzky(Harvard University Press), Swapna Putta(Clinical Research Institute), Daniel S. Weisholtz(Clinical Research Institute), Ellen B. Bubrick(Clinical Research Institute), Hong‐Ren Yu(University of Massachusetts Lowell), Javad Alam(Clinical Research Institute), Nichelle Llewellyn(Clinical Research Institute), Shelley Hurwitz(Harvard University), Rani A. Sarkis(Brigham and Women's Hospital)
Cited by 13
Related Papers
Incidence and mechanisms of cardiorespiratory arrests in epilepsy monitoring units (MORTEMUS): a retrospective study
|The Lancet Neurology|2013|1.1k
Plasma Levels of Insulin-Like Growth Factor-I and Lung Cancer Risk: a Case-Control Analysis
|JNCI Journal of the National Cancer Institute|1999|558
Safety, tolerability, and efficacy of pirfenidone in patients with rheumatoid arthritis-associated interstitial lung disease: a randomised, double-blind, placebo-controlled, phase 2 study
|The Lancet Respiratory Medicine|2022|211
Intensive treatment and survival outcomes in NUT midline carcinoma of the head and neck
|Cancer|2016|210
Rational stepwise approach for Mycoplasma pneumoniae pneumonia in children
|Journal of Microbiology Immunology and Infection|2020|203